Home › Funds › Caligan Partners LP › ADMA

Caligan Partners LP position in ADMA

ADMA BIOLOGICS INC · Health Care

Caligan Partners LP reported holding 300,000 shares of ADMA (ADMA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 0.15% of its reported portfolio and ranking #25 among its reported holdings. Caligan Partners LP has disclosed ADMA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)300.00K sh
Reported value held$2.51M
Portfolio Weight0.15%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's ADMA position evolved

Caligan Partners LP first disclosed a stake in ADMA in Q3 2023 at 597,513 shares (US$2.1M). The position peaked in Q4 2025 at 3,012,508 shares, worth US$54.9M. Across 6 filings, Caligan Partners LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 300,000 shares valued at US$2.5M. Notable position changes include a 90% trim in Q1 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 597.51K $2.14M New
Q4 2023 473.09K $2.14M Reduce
Q3 2025 2.64M $38.65M New
Q4 2025 3.01M $54.95M Add
Q1 2026 300.00K $2.70M Reduce
Q2 2026 300.00K $2.51M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADMA and 13F data

ADMA (ADMA BIOLOGICS INC) is a Health Care company. 18 other funds we track also report a position in ADMA — the largest reported positions include Rubric Capital Management LP (US$78.2M), B Group, Inc. (US$27.3M), Duquesne Family Office LLC (US$23.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADMA

All ADMA fund holders →

FAQ

How long has Caligan Partners LP held ADMA?

Caligan Partners LP has disclosed ADMA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Caligan Partners LP's current position in ADMA?

As of Q2 2026, Caligan Partners LP holds 300.00K shares of ADMA (ADMA BIOLOGICS INC), valued at $2.51M, representing 0.15% of its reported portfolio and ranking #25.

Has Caligan Partners LP been buying or selling ADMA?

In the latest 13F filing (Q2 2026), Caligan Partners LP held unchanged its position in ADMA. The position peaked in Q4 2025 at 3.01M shares.

Which other funds hold ADMA?

Other major institutional holders of ADMA include Rubric Capital Management LP, B Group, Inc., Duquesne Family Office LLC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.